TD Cowen Reaffirms Their Buy Rating on GeneDx Holdings (WGS)
TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...
GeneDx stock holds steady despite fraud allegations
GeneDx (NASDAQ:WGS) shares maintained their ground following a reiteration of a Hold rating and a $75.00 price target by Jefferies analysts. According to InvestingPro data, analyst targets for the ...
BTIG maintains GeneDx stock Buy rating, $95 target amid fraud claim
BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ranging from $70 to $118 ...
GeneDx short report ‘misguided,’ buy on weakness, says Craig-Hallum
The short report out Wednesday morning on GeneDx (WGS) by Grizzly Research alleging that the company utilizes an illegal code-stacking scheme ...
GeneDx targeted in short report by Grizzly Research
In 2022, before changing its name from Sema4 to GeneDx, the company had a dispute with UnitedHealthcare, which resulted in a ...
American Association of Individual Investors3d
Which Is a Better Investment, The Ensign Group, Inc. or GeneDx Holdings Corp. Stock?
Learn more about whether The Ensign Group, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
American Association of Individual Investors3d
Which Is a Better Investment, Clover Health Investments, Corp. or GeneDx Holdings Corp. Stock?
Learn more about whether Clover Health Investments, Corp. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...
PFG Investments LLC Acquires Shares of 3,274 GeneDx Holdings Corp. (NASDAQ:WGS)
PFG Investments LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,274 shares of ...